Brain death evaluation during the pandemic

Ibrahim Migdady, Alexander Rae-Grant, David M. Greer

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) may pose unique challenges to clinicians attempting to diagnose brain death in patients infected with the SARS-CoV-2. Among these challenges is the risk of aerosol generation during the traditional apnea testing using the insufflation technique in addition to the risk of complications due to SARS-CoV-2-related lung disease. In this article, we discuss these challenges and provide further guidance to minimize such risks to ensure safety of healthcare professionals and other patients. We also emphasize the importance of maintaining the standards of brain death determination in this critical time.

Original languageEnglish (US)
Pages (from-to)693-694
Number of pages2
JournalNeurology
Volume95
Issue number15
DOIs
StatePublished - Oct 13 2020
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Brain death evaluation during the pandemic'. Together they form a unique fingerprint.

Cite this